Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

114 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Involuntary smoking cessation: a treatment option in chemical dependency programs for women and children.
Ker M, Leischow S, Markowitz IB, Merikle E. Ker M, et al. Among authors: leischow s. J Psychoactive Drugs. 1996 Jan-Mar;28(1):47-60. doi: 10.1080/02791072.1996.10471714. J Psychoactive Drugs. 1996. PMID: 8714334
Couple dynamics of change-resistant smoking: toward a family consultation model.
Rohrbaugh MJ, Shoham V, Trost S, Muramoto M, Cate RM, Leischow S. Rohrbaugh MJ, et al. Among authors: leischow s. Fam Process. 2001 Spring;40(1):15-31. doi: 10.1111/j.1545-5300.2001.4010100015.x. Fam Process. 2001. PMID: 11288367 Free PMC article. Review.
Smoking is North America's leading cause of preventable morbidity and mortality. Although effective cessation treatments exist, their overall effect is modest, and they rarely reach the high-risk, health-compromised smokers who need them most. ...
Smoking is North America's leading cause of preventable morbidity and mortality. Although effective cessation treatments exist, their …
Tobacco cessation skills certification in Arizona: application of a state wide, community based model for diffusion of evidence based practice guidelines.
Muramoto ML, Connolly T, Strayer LJ, Ranger-Moore J, Blatt W, Leischow R, Leischow S. Muramoto ML, et al. Among authors: leischow r, leischow s. Tob Control. 2000 Dec;9(4):408-14. doi: 10.1136/tc.9.4.408. Tob Control. 2000. PMID: 11106711 Free PMC article.
SETTING: Arizona's comprehensive tobacco control programme of state funded, community based local projects and their community partners providing tobacco treatment services for geographically, socioeconomically, and ethnically diverse communities. ...RESULTS: During the mo …
SETTING: Arizona's comprehensive tobacco control programme of state funded, community based local projects and their community partne …
Efficacy of transdermal nicotine in reducing post-cessation weight gain in a Hispanic sample.
Hill AL, Roe DJ, Taren DL, Muramoto MM, Leischow SJ. Hill AL, et al. Among authors: leischow sj. Nicotine Tob Res. 2000 Aug;2(3):247-53. doi: 10.1080/14622200050147510. Nicotine Tob Res. 2000. PMID: 11082825 Clinical Trial.
Advancing the science of adolescent tobacco use cessation.
Backinger CL, Leischow SJ. Backinger CL, et al. Among authors: leischow sj. Am J Health Behav. 2001 May-Jun;25(3):183-90. doi: 10.5993/ajhb.25.3.4. Am J Health Behav. 2001. PMID: 11322616 Review.
Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence.
Leischow SJ, Valente SN, Hill AL, Otte PS, Aickin M, Holden T, Kligman E, Cook G. Leischow SJ, et al. Exp Clin Psychopharmacol. 1997 Feb;5(1):54-64. doi: 10.1037//1064-1297.5.1.54. Exp Clin Psychopharmacol. 1997. PMID: 9234040 Clinical Trial.
Effects of smoking cessation on caloric intake and weight gain in an inpatient unit.
Leischow SJ, Stitzer ML. Leischow SJ, et al. Psychopharmacology (Berl). 1991;104(4):522-6. doi: 10.1007/BF02245660. Psychopharmacology (Berl). 1991. PMID: 1780423
Responsiveness of the Smoking Cessation Quality of Life (SCQoL) questionnaire.
Shaw JW, Coons SJ, Foster SA, Leischow SJ, Hays RD. Shaw JW, et al. Among authors: leischow sj. Clin Ther. 2001 Jun;23(6):957-69. doi: 10.1016/s0149-2918(01)80083-7. Clin Ther. 2001. PMID: 11440295 Clinical Trial.
Development of the Smoking Cessation Quality of Life questionnaire.
Olufade AO, Shaw JW, Foster SA, Leischow SJ, Hays RD, Coons SJ. Olufade AO, et al. Among authors: leischow sj. Clin Ther. 1999 Dec;21(12):2113-30. doi: 10.1016/s0149-2918(00)87242-2. Clin Ther. 1999. PMID: 10645757 Clinical Trial.
Increasing Smoking Cessation in the United States: Expanding the Availability of Over-the-Counter Medications.
Leischow SJ. Leischow SJ. JAMA. 2019 Feb 12;321(6):541-542. doi: 10.1001/jama.2018.21557. JAMA. 2019. PMID: 30653222 No abstract available.
114 results
Jump to page
Feedback